pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-302b |
Genomic Coordinates | chr4: 112648485 - 112648557 |
Description | Homo sapiens miR-302b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-302b-5p | ||||||||||||||||||||||||||||||
Sequence | 11| ACUUUAACAUGGAAGUGCUUUC |32 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CCNT2 | ||||||||||||||||||||
Synonyms | CYCT2 | ||||||||||||||||||||
Description | cyclin T2 | ||||||||||||||||||||
Transcript | NM_001241 | ||||||||||||||||||||
Other Transcripts | NM_058241 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CCNT2 | |||||||||||||||||||||
3'UTR of CCNT2 (miRNA target sites are highlighted) |
>CCNT2|NM_001241|3'UTR 1 TGCCAATCACGAGTACAGTACAAGCAGCCAGCATATGGACTACAAAGACACATTCGACATGCTGGACTCACTGTTAAGTG 81 CCCAAGGAATGAACATGTAATAATTTGTTTAGGTCAATTTTTCCTTTACTTTTTTAATTTAAAAATTGTTAGAATGGAAA 161 AATTCCTTCTGATCTAGCAGTGGTAACCCCTGCTGTTGCTGCCACTGCTTCAATATTTGTAAGTGCTGCTTTATTCTTCA 241 TTCTGAAAAGAAGAGATTATAGTAAACAAGTCTTTATCTCCACATATGATAGTGTTATAAATACTGTAAAAGCATGGAAG 321 GTGCAAAACTCAGTATTTCTACAATTGCAGCTAAGAACATTAGGATGAATGGCTGGCTGCTTCTAGGAATATAAGATGCC 401 TCAAGCATTCATTATTTATGATTTGAATACTGTAGCTATTTTTTGTTGCTTGGCTTTTGAATGAGTGTAAATTGTTTTCT 481 TTTGTGTATTTATACTTGTATGTATGATTTGCATGTTTCAATGATAAAGGGATAAAACAGTATACTGACAACTGTTTACA 561 AGAAAGTGGAGAAAAATGTACATACATTTTTGTATGTTTAGATATTACCGTAAATACTCAGGATTGGAGCTGCTTGTAAG 641 TATAACAATATACAGAATAACTTTATTTTATCTTGTCAGAGTCCATCACTAATCTAAAACAAAGGTGGCACTTTTTTATG 721 TTAACCTTAAACTCTAGGCCTTACTGGAAGCCACTGATAGGGGACACTTCACTACCAGATGTGTGCAGTGCAACAGATGG 801 TCATATACACTGTGAGGCACTGAAATTTTGCCTTCAGAGGTTCTGACCAGATTGGCTGCTGAAATAGCCCCTAACTTTCT 881 GAAGGCTTGAAGAGGAAAAAATAAAGTTTACATACTCTTGATGTGAAGTGCATTTAAATGTTTGTTGGCTTGTTGCAGTT 961 CTATGAAACAGAGCTGTTAATAATGGTTATGTGGATTACTGTGATTTGAAAACTAAATTCACAATAACTTACCTAGTAGA 1041 GATTTAGTGAGTTGTTTCCTTTAAAGAATTTTACACTACATATTTTAATAGTAAACAGGGATCACTTTTCCTTTAGCATT 1121 CAGAATGACACCATATTCTTAAATATACTCCTTCCCTGAAGCGTGTTTGTGTGTGATGCCATATTTCTTTTTCAGGTAAA 1201 TGTAGTCTTCCTTATAAAAATGAAATTAAACCTATGCTCTCAATTCTTTTATATTCTAACAATAAATAAAAAAGAAAAGA 1281 TTACTGACTGTGCATTGTACCTGTATTTATAGTTTATGGTTATCAGGAAGCTCTGTAAGAAAGAAAAGGTCAGCCTCCCA 1361 GGCAAACCAGTAGTGGAGGTTTTACATTTGTTTGCACATCTCAGTATATTTCTGTTGAGGTAAAGTTTGCACAGTCATCT 1441 GACTTCTGATCAAGCATTAGATTTTAACTTGTTTAGATTTTGTCTTAAACACCAGTAATATGGCTCTTGTTTATCAGCTA 1521 ATCTTGAATTTATTCTGTGGTAAATCTTTTGAGTTGTTGAGTATATTTGAGATTGATTGGATTCGACCTCTTGTTGAACT 1601 GAAAACTTAATTTTTTCTCTGTATTTTTGTTACAAAGCCACTGATACGTGCACAATTGTAATTAAGTATGTTGCAGTTGT 1681 AAATATTAGAGTTTAATCTCATGCTCTACCTTTATTTAGCAATTACCTAATTTGCCAGTAGCTTTATAATTTTTAAAGAT 1761 AATTGTTCATTATTTTGTCAATGTTATTTGAACTTGGGGTACTTAGGAGCCTCTTTGTAGGGACTGTGCCTAGGTAGCAT 1841 GTCCTAACATTTGTTCTGGTCTTGCATAACTTCAGTAATCTTTGTCATTATATGTAACTTTGTTGCTCTGTATGGCATAA 1921 TATTGTATCCATAAACATGGTAATTTTGATACAGTTATACTTTTACAGTGGTACATAATCCAAGGACTAGTATAGAATTA 2001 AGCTGAGTGCAAGATGAGGGAGGGAAGGGCTTTCTTGGTAATTTAGATGTGAAACCTCTACAGAGCTATCATGTAAAAAC 2081 TACATAAGGTGGTTGTGCTACTGTATAATTGGGGGTGATAATACCAGGAATTTTAATAAGATTTTGTAAAGAATATCCAG 2161 AAAAGTAGTGAACTTATTTTCAGTAGACATAGAAAACAATGTGAATATTTAAGGTCTGTGACTATAGTTAAACTTCACTA 2241 AGAATTTGCAGAATTGTTTTGAGATGTGTGAATAAAGGTAATTTTATTGAATCTTCATTGGTGCTAATGATGGACAGTTA 2321 AAAAGATAGCTAGTGTATATTGTTATGGGTCAGTACTTATTAGTACTTCCAAAATTGAATTTGAAATGCTATGTATTCAC 2401 TTTTCACTCTGTAAATGTAATTCTTTACAATGACTTTATTTATTAAAGGGCAGCCAGTTGTCATTTTTACAGGATTGTGT 2481 GAGCTATTCAAACTCTTCAACCCCTGAACAGGGTATTAAGCTTCCAAAATAATGATGGGGATAAATATGGAAATCCTTTT 2561 TAAGTTGTATTTCCATTAAACAAAAACCCTTATAATTCATACTATCATGAATTTGCTTTATCCATCTCATTTGCATAACA 2641 GTTCATCTGTCTGGTCCCATTAGGCTCTACCAAAGAAAGACTCTGATGAGTGGACATTATTACTGTGACTCTTGTAAGTA 2721 GCCATAAATAAACCAAAATAGTATCAAATTTAGGTATGAAATTCCACATGTGCAAAGTACTGTTAAGGTGATAACATTTT 2801 TGATGAGATTTAAAAAAATATTTGAAATATTAAAAAGCATTATCTTTAAACATCCTATAAAAGAGTGAGTCATTTTTAAG 2881 TTGTGTTTTCCCTAGATCACTGATTTGTTACCTTTACACAGAAGCACATTGCAAAGAAAGGCTTTATTTCTACCTCTTCC 2961 ATTCAGTTTTCCAATATTGAGCTGTGTCCCTCTGAATATTTGCCTTAGCTATTTCAAAATAGGTATTTTCAGAACCAAAG 3041 CAAAGGGTGGTTTGTTCACTGAAACATTCTTAGAGGCCTACTTAACGGGCGGCAGTATCCGGTAGTGGTAAAACCTCACA 3121 GTTTCCTAATTGCAGGTATGTAAATACCAAAAAAGTCCTGTTGTCAGCCCTAGGTTTATCTTTGAAAGCAGTTAAATGTG 3201 CACCTTGGTCTTCCTCCGTGTGTTCAGATTCCTTCTGGTTAAAGTTCTTATTCAGAGTCATCTAAAAGAAATTTCTAACA 3281 TGATGTATGGTTTCTTGAATGTCATGAGTGGCTGCGTATATTGCTTTGTAGCAACAGATTGTATTAATAATTAATAGAAT 3361 ACCTAATTTTTTTGGCCTATCCTCTTTGAACTAGAAATGACTACTTGAGGGCTATTTCAGAGAACCAATATGAAATGTTT 3441 TTGTTAGTACAAAATACCATTGCCTTAAAAGGTTTCAAGCACATTTTCTTTTCTATTTGAGAACTTAAATTGCTGACTTG 3521 TATTCGTTAAGCAACCTTAGAAATAAACCACTGCTTATATCTGCATGAATATTATGCATTTCATGAGTACAGTTAGTTGA 3601 TTAGATATTTCAGGGTTTTGCATTTTCTATAGACATGGGGACTTTTTTAACATGGTAACGTCTTAGGAAAACCATTCTCT 3681 CAAGGTATTACACCATTTCCAATTTTATCCAAATGAAAAGCATATCTGCTTAAATTTAGGATGTCTTTGCTGAGAATATT 3761 TGGAGGCTCTTGTTAGGAAGAATCATGGATTCAGTATTTCTAACCTGATTACTGCCTCAGAGGCTGTCTTGAAGGGAGAC 3841 AGTAGGATTCACTGACTACCTTTACCCAGATGAGGGATCAACAAATCTCACACTTAAACTAAATGAGTTGACAGGACAAT 3921 AGGTGCTAATCTCATGTGCCCTAAGATGGACTTATTTAGATAGGGATTTTTGCATTGGAAAAGCAGCACATTCTCTGACC 4001 TTGGGTACCAAGCTATGATACTAATTTGAGAATCACATTCTGATACGTTAATATCAGAAATCAGTGAGCAACCTAATTGC 4081 TGTAAGCTGACATACATGGAAGCCGAAATCAAAAGGTTGCTTTTGTTAGTTTCCCTGGAGCATCTATTTTTGTAATACAT 4161 TTTGCCAGTGGGACTGAAAAGCTCAAAATGTTTTAGACCTAATATCATACATTAATTTTCTGCTCTGCAGTGTCAATTTG 4241 GGCACAGCCAGTTTTTACCTCTGTGGCACCTTCTTTATAATTTACTGTTACCTATTCTGCCTGACAGATTGATTAAGTAG 4321 GTTGATAAGATCCATCGAAGATTGAATGGCTAGGAGTAATTCTGTTCTCGTATAGGCAACTTAACTTCACTGTGGAATCC 4401 ATTTATCTCAAAGTTTGAGGGCTGTCTACTTTATTTTCAAGTTTGGGGCGGAAACTCAAAATCCCGAGCATTGCCACTTT 4481 AGTAGTTTGTTTGATTTGCCTATTGTTTAATAATGAGTACATTCTTATTAAGTGATGAGTACATTCTTAATTTTAAGGTA 4561 TGTTTTTTTCAAGCAGCTTCATTTTATTAGGAAAAATACATACTCATTTGTTGTAAACAGTGATTGTGGGGTTTCATTTT 4641 CTGAATGTACTCAAAACTCCCAACAACAATTGAACAGGATGTTTGCTAATAGAAAATCTAAAACAGGAATATGTGTATAT 4721 GGCATGAATTAGTCATTGACTTTAAGCTTCTTATCCATACAAGGAACTAATAAAATGTTTATTGACAACATAAATCC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-1 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796037. RNA binding protein: AGO2. Condition:4-Thiouridine
PAR-CLIP data was present in GSM796038. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | LCL35 |
Disease | MIMAT0000714 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020022. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM1020022 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL35 / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000295238.6 | 3UTR | UAAAGAAUUUUACACUACAUAUUUUAAUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM796037 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000295238.6 | 3UTR | UAAAGAAUUUUACACUACAUAUUUUAAUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM796038 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000295238.6 | 3UTR | UAAAGAAUUUUACACUACAUAUUUUAAUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
109 hsa-miR-302b-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT088427 | LCLAT1 | lysocardiolipin acyltransferase 1 | 2 | 4 | ||||||||
MIRT142406 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT162006 | TFRC | transferrin receptor | 2 | 2 | ||||||||
MIRT170893 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT203348 | CCNT2 | cyclin T2 | 2 | 4 | ||||||||
MIRT207353 | TGOLN2 | trans-golgi network protein 2 | 2 | 2 | ||||||||
MIRT208232 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 4 | ||||||||
MIRT214733 | HSPA9 | heat shock protein family A (Hsp70) member 9 | 2 | 2 | ||||||||
MIRT254842 | NUP50 | nucleoporin 50 | 2 | 2 | ||||||||
MIRT257285 | FOXC1 | forkhead box C1 | 2 | 2 | ||||||||
MIRT338890 | LLPH | LLP homolog, long-term synaptic facilitation | 2 | 2 | ||||||||
MIRT400032 | USP37 | ubiquitin specific peptidase 37 | 2 | 2 | ||||||||
MIRT404031 | ATP9A | ATPase phospholipid transporting 9A (putative) | 2 | 8 | ||||||||
MIRT405843 | EIF2S1 | eukaryotic translation initiation factor 2 subunit alpha | 2 | 2 | ||||||||
MIRT445847 | FPGT | fucose-1-phosphate guanylyltransferase | 2 | 2 | ||||||||
MIRT446350 | EML6 | echinoderm microtubule associated protein like 6 | 2 | 2 | ||||||||
MIRT446649 | BTBD7 | BTB domain containing 7 | 2 | 2 | ||||||||
MIRT447925 | SCRN1 | secernin 1 | 2 | 2 | ||||||||
MIRT448575 | PLCG1 | phospholipase C gamma 1 | 2 | 2 | ||||||||
MIRT463616 | ZBTB33 | zinc finger and BTB domain containing 33 | 2 | 4 | ||||||||
MIRT465782 | TMOD3 | tropomodulin 3 | 2 | 2 | ||||||||
MIRT470261 | PRR14L | proline rich 14 like | 2 | 2 | ||||||||
MIRT471090 | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | 2 | 2 | ||||||||
MIRT475612 | HMGB1 | high mobility group box 1 | 2 | 2 | ||||||||
MIRT476824 | FNDC3A | fibronectin type III domain containing 3A | 2 | 2 | ||||||||
MIRT483107 | TYRP1 | tyrosinase related protein 1 | 2 | 10 | ||||||||
MIRT500537 | XPO4 | exportin 4 | 2 | 2 | ||||||||
MIRT502525 | EPHA2 | EPH receptor A2 | 2 | 4 | ||||||||
MIRT510989 | PER1 | period circadian clock 1 | 2 | 4 | ||||||||
MIRT512540 | ZNF793 | zinc finger protein 793 | 2 | 4 | ||||||||
MIRT513868 | HOXA5 | homeobox A5 | 2 | 2 | ||||||||
MIRT520756 | TFDP1 | transcription factor Dp-1 | 2 | 6 | ||||||||
MIRT524304 | CTC1 | CST telomere replication complex component 1 | 2 | 8 | ||||||||
MIRT526306 | JAKMIP2 | janus kinase and microtubule interacting protein 2 | 2 | 2 | ||||||||
MIRT526378 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT527438 | COL4A3 | collagen type IV alpha 3 chain | 2 | 2 | ||||||||
MIRT527511 | ZNF134 | zinc finger protein 134 | 2 | 2 | ||||||||
MIRT528068 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT528367 | ZMYM1 | zinc finger MYM-type containing 1 | 2 | 4 | ||||||||
MIRT531804 | TFCP2L1 | transcription factor CP2 like 1 | 2 | 2 | ||||||||
MIRT532323 | DUSP4 | dual specificity phosphatase 4 | 2 | 2 | ||||||||
MIRT532431 | DHX33 | DEAH-box helicase 33 | 2 | 2 | ||||||||
MIRT534523 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT536660 | INIP | INTS3 and NABP interacting protein | 2 | 2 | ||||||||
MIRT538488 | CLOCK | clock circadian regulator | 2 | 2 | ||||||||
MIRT538593 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT539706 | EIF3H | eukaryotic translation initiation factor 3 subunit H | 2 | 2 | ||||||||
MIRT540306 | GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | 2 | 2 | ||||||||
MIRT546892 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT552738 | YRDC | yrdC N6-threonylcarbamoyltransferase domain containing | 2 | 2 | ||||||||
MIRT552781 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT553742 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | 2 | 4 | ||||||||
MIRT553909 | SUMO2 | small ubiquitin-like modifier 2 | 2 | 2 | ||||||||
MIRT554540 | RRS1 | ribosome biogenesis regulator homolog | 2 | 2 | ||||||||
MIRT555319 | PPP2CB | protein phosphatase 2 catalytic subunit beta | 2 | 2 | ||||||||
MIRT555512 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | 2 | 2 | ||||||||
MIRT556221 | MB21D2 | Mab-21 domain containing 2 | 2 | 2 | ||||||||
MIRT556292 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 2 | 2 | ||||||||
MIRT556606 | LDOC1L | retrotransposon Gag like 6 | 2 | 4 | ||||||||
MIRT556901 | ISOC1 | isochorismatase domain containing 1 | 2 | 2 | ||||||||
MIRT557675 | GATA6 | GATA binding protein 6 | 2 | 2 | ||||||||
MIRT560198 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT560493 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 2 | ||||||||
MIRT566069 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT568431 | GDNF | glial cell derived neurotrophic factor | 2 | 2 | ||||||||
MIRT570703 | FAM69A | family with sequence similarity 69 member A | 2 | 2 | ||||||||
MIRT571705 | RPL36A-HNRNPH2 | RPL36A-HNRNPH2 readthrough | 2 | 2 | ||||||||
MIRT573152 | ITGA9 | integrin subunit alpha 9 | 2 | 2 | ||||||||
MIRT574410 | TFAP2A | transcription factor AP-2 alpha | 2 | 2 | ||||||||
MIRT614823 | PVRL4 | nectin cell adhesion molecule 4 | 2 | 2 | ||||||||
MIRT616507 | COX7A2L | cytochrome c oxidase subunit 7A2 like | 2 | 2 | ||||||||
MIRT618301 | COL4A4 | collagen type IV alpha 4 chain | 2 | 2 | ||||||||
MIRT621188 | FAM153B | family with sequence similarity 153 member B | 2 | 2 | ||||||||
MIRT621594 | WT1 | Wilms tumor 1 | 2 | 2 | ||||||||
MIRT623814 | GGCX | gamma-glutamyl carboxylase | 2 | 2 | ||||||||
MIRT624407 | CCDC171 | coiled-coil domain containing 171 | 2 | 2 | ||||||||
MIRT625136 | CKAP2L | cytoskeleton associated protein 2 like | 2 | 2 | ||||||||
MIRT626121 | MRRF | mitochondrial ribosome recycling factor | 2 | 2 | ||||||||
MIRT626874 | AP3B1 | adaptor related protein complex 3 beta 1 subunit | 2 | 2 | ||||||||
MIRT627874 | PAN2 | PAN2 poly(A) specific ribonuclease subunit | 2 | 2 | ||||||||
MIRT633670 | FAM53B | family with sequence similarity 53 member B | 2 | 2 | ||||||||
MIRT634285 | SYAP1 | synapse associated protein 1 | 2 | 2 | ||||||||
MIRT640925 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT642028 | MYADM | myeloid associated differentiation marker | 2 | 2 | ||||||||
MIRT643031 | CHCHD7 | coiled-coil-helix-coiled-coil-helix domain containing 7 | 2 | 2 | ||||||||
MIRT646122 | SLC26A9 | solute carrier family 26 member 9 | 2 | 2 | ||||||||
MIRT646245 | SNAP47 | synaptosome associated protein 47 | 2 | 2 | ||||||||
MIRT652457 | TMEM2 | transmembrane protein 2 | 2 | 2 | ||||||||
MIRT657018 | KCNK5 | potassium two pore domain channel subfamily K member 5 | 2 | 2 | ||||||||
MIRT660586 | APP | amyloid beta precursor protein | 2 | 2 | ||||||||
MIRT664316 | CD209 | CD209 molecule | 2 | 2 | ||||||||
MIRT667113 | OLA1 | Obg like ATPase 1 | 2 | 2 | ||||||||
MIRT668773 | DCP2 | decapping mRNA 2 | 2 | 2 | ||||||||
MIRT698430 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT700216 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT710498 | CAPRIN1 | cell cycle associated protein 1 | 2 | 2 | ||||||||
MIRT711836 | AMOTL2 | angiomotin like 2 | 2 | 2 | ||||||||
MIRT713226 | GPR75 | G protein-coupled receptor 75 | 2 | 2 | ||||||||
MIRT714415 | TBC1D16 | TBC1 domain family member 16 | 2 | 2 | ||||||||
MIRT714490 | HSPA4 | heat shock protein family A (Hsp70) member 4 | 2 | 2 | ||||||||
MIRT715254 | F9 | coagulation factor IX | 2 | 2 | ||||||||
MIRT716250 | PALM2 | paralemmin 2 | 2 | 2 | ||||||||
MIRT717261 | BMPR2 | bone morphogenetic protein receptor type 2 | 2 | 2 | ||||||||
MIRT717730 | FGF1 | fibroblast growth factor 1 | 2 | 2 | ||||||||
MIRT719262 | CD44 | CD44 molecule (Indian blood group) | 2 | 2 | ||||||||
MIRT719398 | SLC15A4 | solute carrier family 15 member 4 | 2 | 2 | ||||||||
MIRT720653 | TMEM218 | transmembrane protein 218 | 2 | 2 | ||||||||
MIRT720777 | MSANTD3-TMEFF1 | MSANTD3-TMEFF1 readthrough | 2 | 2 | ||||||||
MIRT722059 | TMEFF1 | transmembrane protein with EGF like and two follistatin like domains 1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|